Thyrocare Technologies Limited

Equities

THYROCARE

INE594H01019

Healthcare Facilities & Services

Market Closed - Bombay S.E. Other stock markets 06:29:51 2024-04-26 am EDT			5-day change	1st Jan Change
651.7 ^INR	-1.25%		+2.65%	+1.27%

Apr. 16	Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	CI
Feb. 28	Thyrocare Technologies Completes Acquisition of Think Health; Shares Jump 6%	MT

Thyrocare Technologies Limited completed the acquisition of Think Health Diagnostic Private Limited.

February 26, 2024

Thyrocare Technologies Limited (BSE:539871) agreed to acquire Think Health Diagnostic Private Limited for INR 3.2 million on February 1, 2024. As of March 31, 2023, Think Health Diagnostic Private Limited generated revenue of INR 7.9 million.

Thyrocare Technologies Limited (BSE:539871) completed the acquisition of Think Health Diagnostic Private Limited on February 27, 2024. Think Health has become wholly-owned subsidiary company of Thyrocare.

Latest news about Thyrocare Technologies Limited

Thyrocare Technologies Limited Announces Resignation of Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	Apr. 16	CI
Thyrocare Technologies Completes Acquisition of Think Health; Shares Jump 6%	Feb. 28	MT
Thyrocare Technologies Limited completed the acquisition of Think Health Diagnostic Private Limited.	Feb. 26	CI
Thyrocare Technologies Limited Pays and Settles Due Cess Amount Including Interest and Penalty Amount to Navi Mumbai Municipal Corporation, Cess Department	Feb. 23	CI
Thyrocare Technologies Appoints Chief Commercial Officer	Feb. 22	MT
Thyrocare Technologies Limited Appoints Nitin Chugh as Chief Commercial Officer	Feb. 22	CI
Thyrocare Technologies Posts Gains in Fiscal Q3 Consolidated Profit	Feb. 02	MT
Transcript : Thyrocare Technologies Limited, Q3 2024 Earnings Call, Feb 01, 2024	Feb. 01
Thyrocare Technologies Limited Appoints Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer	Feb. 01	CI
Thyrocare Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 01	CI
India's Dr. Lal PathLabs posts 54% jump in Q3 profit on flu, COVID tests	Feb. 01	RE
Thyrocare Technologies to Acquire 100% Stake in Think Health Diagnostic	Feb. 01	MT
Thyrocare Technologies Limited agreed to acquire Think Health Diagnostic Private Limited for INR 3.2 million.	Jan. 31	CI
Transcript : Thyrocare Technologies Limited, Q2 2024 Earnings Call, Oct 31, 2023	23-10-31
Indian shares set to open lower with HDFC, Fed decision in focus	23-09-19	RE
Thyrocare Technologies Forms Joint Venture in Tanzania	23-09-19	MT
Thyrocare Technologies Limited Enter into A Subscription Agreement At Tanzania with Kastipharm Limited and Other Individuals for Setting Up A Joint Venture Company	23-09-19	CI
Thyrocare Technologies Names CFO	23-08-01	MT
Transcript : Thyrocare Technologies Limited, Q1 2024 Earnings Call, Aug 01, 2023	23-08-01
Thyrocare Technologies Limited Appoints Alok Kumar Jagnani as Chief Financial Officer	23-08-01	CI
Thyrocare Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-01	CI
Thyrocare Technologies CFO Resigns	23-07-16	MT
Thyrocare Technologies Limited Accepts Resignation of Sachin Salvi as Chief Financial Officer	23-07-14	CI
Thyrocare Technologies Posts Lower Fiscal Q4 Net Profit	23-05-24	MT
Transcript : Thyrocare Technologies Limited, Q4 2023 Earnings Call, May 23, 2023	23-05-23

Chart Thyrocare Technologies Limited

Duration

Period

More charts

Company Profile

Thyrocare Technologies Limited is an India-based healthcare services provider in diagnostic area. The Company has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that is focused on early detection and management of health disorders and diseases. The Company's segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceutical, selling of consumables for reporting. The Others segment include the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. The Company has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India.

Sector

Healthcare Facilities & Services

Calendar

2024-05-02 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Thyrocare Technologies Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

651.7 INR

Average target price

727.5 INR

Spread / Average Target

+11.63%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
THYROCARE TECHNOLOGIES LIMITED	+1.27%	414M
SONIC HEALTHCARE LIMITED	-17.89%	8.25B
RADNET, INC.	+39.20%	3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-39.11%	2.46B
SYNLAB AG	-8.06%	2.46B
DR. LAL PATHLABS LIMITED	-7.35%	2.38B
NEOGENOMICS, INC.	-12.61%	1.81B
FLEURY S.A.	-19.01%	1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-40.66%	1.21B
METROPOLIS HEALTHCARE LIMITED	+7.56%	1.11B

Medical & Diagnostic Laboratories